Tender Title: Supply of Cytokeratin 20, Her 2 Neu, and WT1

Tender Reference Number: GEM/2025/B/6118944
Issuing Authority: Department of Health and Family Welfare, Ministry of Health and Family Welfare

The supply tender for Cytokeratin 20, Her 2 Neu, and WT1 aims to procure specialized medical reagents essential for diagnostic and therapeutic purposes in healthcare facilities across the region. This tender is crucial for ensuring that health institutions have access to necessary diagnostic tools that facilitate the early detection and treatment of diseases, thereby improving patient outcomes.

Scope of Work and Objectives

The scope of work encompasses the procurement of high-quality diagnostic reagents specifically designed for the testing and evaluation of Cytokeratin 20, Her 2 Neu, and WT1 markers. These markers are vital in oncological research and diagnostics, particularly in the assessment of various cancers. The objectives include:

• Providing reliable and accurate reagents to healthcare facilities.
• Ensuring timely delivery to meet the demands of healthcare providers.
• Contributing to improved health outcomes through advanced diagnostic measures.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet the following eligibility requirements:

• Be a registered entity in the relevant sector.
• Have prior experience in supplying medical reagents or similar products to healthcare institutions.
• Possess necessary licenses and certifications as mandated by healthcare regulations.

Technical Requirements

Bidders are required to submit products that meet prescribed quality standards. Key technical requirements include:

• Compliance with established medical and safety regulations.
• Evidence of product-testing certifications.
• Details about the manufacturing process and quality assurance measures.

Financial Requirements

Bidders must provide detailed financial documents accompanied by a declaration of compliance with standard financial practices. This includes:

• Proof of financial stability.
• Submission of pricing structures in accordance with the estimated quantity of 5 units.

Document Submission Details

All tender documents must be submitted electronically through the designated portal. Required documents include:

• Bid proposal in the required format.
• Relevant certifications and licenses.
• Proof of previous experience and references from healthcare institutions.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and relevant start-ups by providing a supportive framework to ensure participation. These provisions include:

• Relaxed eligibility criteria and documentation requirements for MSEs.
• Guidance on navigating the tender application process.

Evaluation Process

The evaluation process will focus on:

• Compliance with technical specifications.
• Price evaluation to ensure the best financial offer.
• Assessment of the bidder’s ability to meet delivery timelines and quality standards.

Delivery Locations

Successful bidders will be required to deliver the specified reagents to locations designated by the Department of Health and Family Welfare throughout the region. Delivery logistics must be established within the bid proposal.

Contact Information

Bidders seeking additional information or clarification regarding this tender are encouraged to reach out to the Department of Health and Family Welfare via the official contact channels provided on the tender portal.

The successful execution of this tender will play a pivotal role in enhancing the diagnostic capabilities of healthcare institutions, thus directly impacting the overall healthcare services offered to the community.